The Glucose Random Test evaluates glucose levels in the blood without requiring fasting, making it useful for detecting abnormal sugar regulation. Elevated or low results may suggest diabetes, prediabetes, or hypoglycemia. This test supports assessment of metabolic function, carbohydrate processing, and systemic health, offering insight into symptoms like thirst, frequent urination, or unexplained fatigue.

The Glucose Tolerance Test, 4 Specimens evaluates blood glucose at fasting, 1-hour, 2-hour, and 3-hour intervals after a glucose drink. This test is an important tool for diagnosing or screening for prediabetes, type 2 diabetes, and impaired glucose metabolism. Measuring glucose response across multiple specimens provides valuable data on insulin function, carbohydrate handling, and overall metabolic health.

The Glucose Tolerance Test, 5 Specimens evaluates glucose response at fasting, 1, 2, 3, and 4 hours after a standard glucose drink. By analyzing multiple specimens, it identifies impaired glucose tolerance, prediabetes, and type 2 diabetes. The test provides clinicians with extensive information on insulin function, glucose regulation, and the progression of metabolic disorders that affect long-term health outcomes.

The Glucose Plasma Test measures the amount of glucose in the blood to assess how the body regulates sugar. Abnormal results may indicate diabetes, prediabetes, hypoglycemia, or other metabolic disorders. Doctors order this test for patients with symptoms like fatigue, excessive thirst, or frequent urination. It is also commonly used for routine health screening, monitoring diabetes treatment, and guiding lifestyle or medication adjustments.

 The 2 Hour Fasting and Postprandial Glucose Test is a diagnostic procedure that measures the body's ability to metabolize glucose (sugar) and respond to insulin. It involves taking two blood samples: one after an overnight fast and another two hours after consuming a meal.

The Fasting and Gestational Glucose Test, 135 Cutoff evaluates fasting glucose and post-load blood sugar one hour after a 50-gram glucose challenge. A 135 mg/dL cutoff helps identify women at increased risk for gestational diabetes who may require follow-up testing. This test offers valuable information about maternal carbohydrate metabolism, insulin activity, and abnormal glucose regulation in pregnancy.

The C-Peptide Response to Glucose Test with 2 specimens evaluates pancreatic beta cell activity and insulin secretion during glucose intake. By measuring changes in C-peptide levels at two time points, it helps assess insulin production, glucose regulation, and potential insulin resistance or diabetes-related disorders. This test offers insight into metabolic health and endocrine function.

The Glucose Tolerance Test, 6 Specimens evaluates blood sugar response at fasting and hourly intervals up to 5 hours after ingestion of a glucose solution. This test provides a comprehensive assessment of glucose metabolism, helping detect impaired glucose tolerance, prediabetes, and diabetes risk. Measuring six specimens reveals detailed patterns of insulin function, metabolic regulation, and progression to chronic disease.

The Glucose Tolerance Test, 7 Specimens evaluates blood sugar at fasting and six hourly intervals after ingestion of a glucose solution, spanning 6 hours of monitoring. It is used to identify prediabetes, diabetes, and impaired glucose regulation. By analyzing seven specimens, the test reveals patterns in insulin function, metabolic regulation, and progression of abnormalities that impact long-term health.

The C-Peptide Response to Glucose Test with 5 specimens measures pancreatic beta cell activity and insulin secretion across five timed intervals. Tracking C-peptide levels over multiple points provides detailed insight into glucose regulation, insulin resistance, hypoglycemia, and diabetes risk, supporting evaluation of metabolic balance and overall endocrine health.

The Gestational Glucose Screen, 50g, 135 Cutoff evaluates maternal blood sugar one hour after a 50-gram glucose drink to screen for gestational diabetes risk. A threshold of 135 mg/dL helps determine the need for follow-up glucose tolerance testing. This test offers important information on maternal carbohydrate metabolism, insulin function, and potential complications related to abnormal glucose regulation in pregnancy.

The C-Peptide Response to Glucose Test with 3 specimens measures pancreatic beta cell function and insulin secretion at multiple time points. Tracking C-peptide levels across three collections provides insight into insulin production, glucose regulation, and metabolic health, supporting evaluation of diabetes risk, hypoglycemia, and overall endocrine function.

The C-Peptide Response to Glucose Test with 4 specimens measures pancreatic beta cell activity and insulin secretion across four timed intervals. Tracking C-peptide changes provides insight into glucose regulation, insulin production, and metabolic function, helping evaluate diabetes risk, hypoglycemia, insulin resistance, and overall endocrine health.

The C-Peptide Response to Glucose Test with 6 specimens measures pancreatic beta cell activity and insulin secretion at six timed intervals. Tracking C-peptide levels across multiple points provides a detailed profile of insulin production, glucose regulation, and metabolic health, supporting assessment of insulin resistance, hypoglycemia, diabetes risk, and overall endocrine function.

The C-Peptide Response to Glucose Test with 7 specimens measures pancreatic beta cell activity and insulin secretion across seven timed intervals. Monitoring C-peptide changes over multiple collections provides detailed insight into insulin production, glucose regulation, and metabolic balance, supporting evaluation of diabetes risk, hypoglycemia, insulin resistance, and endocrine system health.

The C-Peptide Response to Glucose Test with 8 specimens measures pancreatic beta cell activity and insulin secretion across eight timed intervals. Monitoring C-peptide levels provides a detailed profile of insulin production, glucose regulation, and metabolic balance, helping identify insulin resistance, hypoglycemia, diabetes risk, and overall endocrine function.

The C-Peptide Response to Glucose Test with 9 specimens measures pancreatic beta cell activity and insulin secretion across nine timed intervals. Tracking C-peptide patterns provides detailed insight into insulin production, glucose regulation, and metabolic health, supporting the detection of insulin resistance, diabetes risk, hypoglycemia, and overall endocrine function.

 The 1 Hour Fasting and Postprandial Glucose test is a two-part diagnostic evaluation that first measures the glucose level in the blood after an overnight fast and then assesses it again one hour after consuming a glucose-rich meal or drink.

The Insulin Response to Glucose Test, 5 Specimens evaluates insulin secretion at fasting and multiple post-glucose solution intervals. This expanded assessment highlights beta-cell function, insulin sensitivity, and abnormalities in carbohydrate metabolism. Results offer valuable information on how the body clears glucose and help identify insulin resistance, metabolic dysfunction, and diabetes-related risks.

The Insulin Response to Glucose Test, 6 Specimens evaluates insulin secretion and glucose regulation with fasting and five post-glucose solution samples. This comprehensive approach highlights beta-cell activity, insulin resistance, and abnormalities in carbohydrate metabolism. Results show how efficiently the body clears glucose, supporting early detection of metabolic dysfunction, prediabetes, and diabetes risk.

The Insulin Response to Glucose Test, 3 Specimens evaluates insulin secretion at three time points: fasting and after drinking a glucose solution at set intervals. This approach helps identify abnormal insulin sensitivity, altered beta-cell activity, and impaired carbohydrate metabolism. Results provide essential information about how efficiently the body regulates glucose, supporting early detection of insulin resistance or diabetes risk.